Skip to main content

Advertisement

Log in

Elevation in creatine kinase isoenzyme-MM associated with hepatocellular carcinoma: a case report and review of literature

  • Case Report
  • Published:
Clinical Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

We report the case of a 79-year-old woman with hepatocellular carcinoma (HCC) who presented with creatine kinase (CK)-MM elevation. On admission, her serum CK-MM level exceeded 4000 IU/L (normal, 44–206 IU/L), and computed tomography revealed two HCCs in hepatic segment VIII (23 mm, 86 mm). The patient denied experiencing muscular symptoms such as weakness or pain. Hypothyroidism, ischemic heart disease, muscular dystrophy, autoimmune myopathy, drug-induced rhabdomyolysis, and paraneoplastic inflammatory myositis syndrome (PIMS) were included in the differential diagnosis for high CK-MM, but none were suspected. Although the cause of elevated CK-MM was not elucidated, an HCC-related mechanism was considered and the tumor was resected. The CK-MM levels declined gradually to 300 IU/L postoperatively without any special perioperative management. Nineteen cases of HCC-associated CK-MM elevation have been reported in English thus far, in all of which, inflammatory myositis was concluded as the cause of CK-MM elevation. However, in this case, the elevation of CK-MM was associated with HCC-related mechanisms distinct from PIMS, suggesting HCC-related mechanisms should not be excluded as a cause of high CK-MM, even though PIMS is negative.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Wyss M, Kaddurah-Daouk R. Creatine and creatinine metabolism. Physiol Rev. 2000;80:1107–213.

    Article  CAS  Google Scholar 

  2. Kazak L, Cohen P. Creatine metabolism: energy homeostasis, immunity and cancer biology. Nat Rev Endocrinol. 2020;16:421–36.

    Article  Google Scholar 

  3. Bárdos D, Molnár MJ, Dudás I, et al. Polymyositis and rhabdomyolysis caused by hepatocellular carcinoma—case report and literature review. Ann Med Surg (Lond). 2021;65:102269.

    Article  Google Scholar 

  4. Sattar MA, Guindi RT, Khan RA, et al. Polymyositis and hepatocellular carcinoma. Clin Rheumatol. 1988;7:538–42.

    CAS  PubMed  Google Scholar 

  5. Horie Y, Yamada M, Nakai K, et al. Combined hepatocellular-cholangiocarcinoma associated with dermatomyositis. J Gastroenterol Hepatol. 1989;4:101–4.

    Article  CAS  Google Scholar 

  6. Hasegawa K, Uesugi H, Kubota K, et al. Polymyositis as a paraneoplastic manifestation of hepatocellular carcinoma. Hepatogastroenterology. 2000;47:1425–7.

    CAS  PubMed  Google Scholar 

  7. Inuzuka M, Tomita K, Tokura Y, et al. Acquired ichthyosis associated with dermatomyositis in a patient with hepatocellular carcinoma. Br J Dermatol. 2001;144:416–7.

    Article  CAS  Google Scholar 

  8. Cheng TI, Tsou MH, Yang PS, et al. Dermatomyositis and erythrocytosis associated with hepatocellular carcinoma. J Gastroenterol Hepatol. 2002;17:1239–40.

    Article  Google Scholar 

  9. Kim MJ, Kim JA, Sung MS, et al. Hepatocellular carcinoma, polymyositis, rhabdomyolysis, and acute renal failure. J Korean Med Sci. 2004;19:891–4.

    Article  Google Scholar 

  10. Kee KM, Wang JH, Lee CM, et al. Chronic hepatitis C virus infection associated with dermatomyositis and hepatocellular carcinoma. Chang Gung Med J. 2004;27:834–9.

    PubMed  Google Scholar 

  11. Toshikuni N, Torigoe R, Mitsunaga M, et al. Dermatomyositis associated with hepatocellular carcinoma in an elderly female patient with hepatitis C virus-related liver cirrhosis. World J Gastroenterol. 2006;12:1641–4.

    Article  Google Scholar 

  12. Kee SJ, Kim TJ, Lee SJ, et al. Dermatomyositis associated with hepatitis B virus-related hepatocellular carcinoma. Rheumatol Int. 2009;29:595–9.

    Article  Google Scholar 

  13. Apostolidis L, Kahlert C, Siegmund A, et al. Remission of paraneoplastic dermatomyositis associated with hepatocellular carcinoma under prednisolone and azathiopin, and concommittant sorafenib. Onkologie. 2009;32:50–3.

    PubMed  Google Scholar 

  14. Kishore D, Khurana V, Raj A, et al. Hepatocellular carcinoma presenting as polymyositis: a paraneoplastic syndrome. Ann Saudi Med. 2011;31:533–5.

    Article  Google Scholar 

  15. Tekaya R, Abdelghni K, Abdelmoula L, et al. Hepatocellular carcinoma with polymyositis as an initial symptom: a case report. Acta Clin Belg. 2011;66:53–4.

    Article  CAS  Google Scholar 

  16. Yang SY, Cha BK, Kim G, et al. Dermatomyositis associated with hepatitis B virus-related hepatocellular carcinoma. Korean J Intern Med. 2014;29:231–5.

    Article  Google Scholar 

  17. Thanapirom K, Aniwan S, Treeprasertsuk S. Polymyositis associated with hepatitis B virus cirrhosis and advanced hepatocellular carcinoma. ACG Case Rep J. 2014;1:167–9.

    Article  Google Scholar 

  18. Miyata N, Emoto K, Dei Y, et al. Paraneoplastic dermatomyositis in hepatocellular carcinoma with colonic perforation: a case report. Case Rep Oncol. 2016;9:547–53.

    Article  Google Scholar 

  19. Chou JW, Lin YL, Cheng KS, et al. Dermatomyositis induced by hepatitis B virus-related hepatocellular carcinoma: a case report and review of the literature. Intern Med. 2017;56:1831–7.

    Article  Google Scholar 

  20. Han J, Wang S, Kwong TNY, et al. Dermatomyositis as an extrahepatic manifestation of hepatitis B virus-related hepatocellular carcinoma: a case report and literature review. Med (Baltim). 2018;97:e11586.

    Article  Google Scholar 

  21. Meng-Ko T, Yi-Hsin C, You-Hsin C, et al. Hepatocellular carcinoma-associated polymyositis presenting with unilateral upper limb subcutaneous edema. Arch Rheumatol. 2018;33:482–7.

    Article  Google Scholar 

  22. Bottai M, Tjärnlund A, Santoni G, et al. EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a methodology report. RMD Open. 2017;3:e000507.

    Article  Google Scholar 

  23. Carney DN, Zweig MH, Ihde DC, et al. Elevated serum creatine kinase BB levels in patients with small cell lung cancer. Cancer Res. 1984;44:5399–403.

    CAS  PubMed  Google Scholar 

  24. Zarghami N, Giai M, Yu H, et al. Creatine kinase BB isoenzyme levels in tumour cytosols and survival of breast cancer patients. Br J Cancer. 1996;73:386–90.

    Article  CAS  Google Scholar 

  25. Meffert G, Gellerich FN, Margreiter R, et al. Elevated creatine kinase activity in primary hepatocellular carcinoma. BMC Gastroenterol. 2005;5:9.

    Article  Google Scholar 

  26. Kanemitsu F, Kawanishi I, Mizushima J, et al. Mitochondrial creatine kinase as a tumor-associated marker. Clin Chim Acta. 1984;138:175–83.

    Article  CAS  Google Scholar 

  27. Soroida Y, Ohkawa R, Nakagawa H, et al. Increased activity of serum mitochondrial isoenzyme of creatine kinase in hepatocellular carcinoma patients predominantly with recurrence. J Hepatol. 2012;57:330–6.

    Article  CAS  Google Scholar 

  28. Vaubourdolle M, Chazouilleres O, Poupon R, et al. Creatine kinase-BB: a marker of liver sinusoidal damage in ischemia-reperfusion. Hepatology. 1993;17:423–8.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nobuyuki Takemura.

Ethics declarations

Conflict of interests

The authors declare that they have no conflict of interest.

Ethical approval

This article satisfied the consensus of the National Center for Global Health and Medicine Research Ethics Committee/Institutional Review Board.

Informed consent

Written informed consent was obtained from the patient described in this study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nakamura, Y., Ito, K., Takemura, N. et al. Elevation in creatine kinase isoenzyme-MM associated with hepatocellular carcinoma: a case report and review of literature. Clin J Gastroenterol 15, 460–466 (2022). https://doi.org/10.1007/s12328-022-01612-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12328-022-01612-w

Keywords

Navigation